HCmed Innovations provides a comprehensive drug-device combination platform supported by a portfolio based on vibrating mesh nebulizers.

Our mission is to create products that are highly integrated for affordable-best-quality, featuring nebulization of high value therapeutic drugs that include antibiotics, suspensions, and difficult-to-deliver formulations, such as biologic drugs.

By combining the strength of Taiwan’s world-class manufacturing industry and a well-established GMP certified manufacturing facility, our leading product, a mesh nebulizer, has received approval from multiple international health authorities and has also been launched in selected markets.

HCmed is prompt to expand its combination development and continue to bring significant value to global pharma partners through a cost efficient and risk minimized pathway, aiming to provide products that enhance treatment efficacy and patient compliance.